Skip to main content
. 2017 Feb;102(2):356–363. doi: 10.3324/haematol.2016.154039

Figures 2.

Figures 2.

Interim positron emission tomography (iPET)-negative (n=101) versus iPET-positive (n=42). (A) Progression-free survival (PFS): 2-year PFS for iPET-negative versus iPET-positive patients. (B) Overall survival: 2-year OS for iPET-negative versus iPET-positive patients.